ArticleJournal of endocrinological investigation2024

Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy.

A R Gosmanov et al.PubMed ↗Publisher ↗

No numbers read from the abstract.